Here is how Compass Therapeutics, Inc. (CMPX) and Ekso Bionics (EKSO) have performed compared to their sector so far this ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

The Honey Pot Company, LLC ('The Honey Pot Co.” or 'the Company”), a leading 'better-for-you” feminine care brand and ...

COMPASS Pathways (NASDAQ:CMPS) used an investor update webinar to highlight positive results from its Phase III COMP005 and ...

COMPASS Pathways plc (NASDAQ:CMPS) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. COMPASS Pathways plc (NASDAQ:CMPS) is given fourth position on our list of most promising ...

Nui Care's "Pflege-Kompass" makes reports understandable, and "Pflege-Tinder" connects relatives. This eases home care burden.

Common symptoms can include itchy skin, constipation, fatigue, mood changes and headaches. More serious complications can include migraines, heart palpitations and heart attacks. In addition, all this ...

Happy Valentine’s Day! It’s a good time for us to emphasize heart-healthy habits to make sure we – and the ones we love – can celebrate Valentine’s Day together for years to come. American Heart ...

F OR FIVE years biotech startups have been betting that psychedelic substances could be turned into real medicines. One of them may have hit the jackpot. On February 17th Compass ...

Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to ...

New subscription platform brings validated nonprofit data into one workspace to save time; expands discovery beyond ...

"In my prior column, 'Admissibility of Medical Records Update,' NYLJ, Dec. 19, 2025, p. 3, col. 3, I discussed the Second ...